Today, FinnCap Reiterates Under Review Rating for Dechra Pharmaceuticals plc (DPH)

Today, FinnCap Reiterates Under Review Rating for Dechra Pharmaceuticals plc (DPH)

Dechra Pharmaceuticals plc (LON:DPH)‘s stock had its “under review” rating restated by research analysts at FinnCap in a research report issued on Tuesday.

A number of other equities analysts also recently commented on the company. Numis Securities Ltd reissued an “add” rating and set a GBX 1,520 ($18.86) price objective on shares of Dechra Pharmaceuticals plc in a research report on Thursday, October 27th. N+1 Singer boosted their price objective on Dechra Pharmaceuticals plc from GBX 1,350 ($16.75) to GBX 1,412 ($17.52) and gave the stock a “buy” rating in a research report on Friday, October 21st. Stifel Nicolaus reaffirmed a “hold” rating and issued a GBX 1,250 ($15.51) price target on shares of Dechra Pharmaceuticals plc in a report on Friday, October 21st. Panmure Gordon reaffirmed a “buy” rating and issued a GBX 1,140 ($14.14) price target on shares of Dechra Pharmaceuticals plc in a report on Sunday, September 11th. Finally, Jefferies Group upped their price target on Dechra Pharmaceuticals plc from GBX 1,229 ($15.25) to GBX 1,295 ($16.07) and gave the company a ” hold” rating in a report on Wednesday, September 7th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of GBX 1,333.86 ($16.55).

Dechra Pharmaceuticals plc (LON:DPH) opened at 1275.00 on Tuesday. Dechra Pharmaceuticals plc has a 52-week low of GBX 811.00 and a 52-week high of GBX 1,462.00. The stock’s market capitalization is GBX 1.18 billion. The firm’s 50-day moving average is GBX 1,326.89 and its 200-day moving average is GBX 1,267.41.

The company also recently disclosed a dividend, which was paid on Friday, November 18th. Shareholders of record on Thursday, October 27th were paid a GBX 12.91 ($0.16) dividend. The ex-dividend date was Thursday, October 27th. This represents a yield of 0.92%. This is a boost from Dechra Pharmaceuticals plc’s previous dividend of $5.55.

Related posts

Leave a Comment